Analystreport

SpringWorks Therapeutics (NASDAQ: SWTX) is now covered by analysts at JPMorgan Chase & Co.. They set an "overweight" rating and a $32.00 price target on the stock.

SpringWorks Therapeutics, Inc. - common stock  (SWTX) 
Last springworks therapeutics, inc. - common stock earnings: 3/12 04:30 pm Check Earnings Report